$VRTX insider trading

Over the last 12 months, Vertex Pharmaceuticals Inc / Ma insiders reported no purchases and 9 sales totaling $6.6M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.

$6.6M
9
4
100%
Side
$100K$1.0M$10MMay '26JunJulAug
Bozic Carmen
Liu Joy
Tatsis Ourania
McKechnie Duncan

All insider trades

Jul 2, 2026Tatsis Ourania▼ Sale1,500$524.99$787K-3.2%
Jul 2, 2026McKechnie Duncan▼ Sale1,541$519$800K-12.3%
Jul 1, 2026Liu Joy▼ Sale828$502.71$416K-4.1%
Jun 26, 2026Bozic Carmen▼ Sale596$482.5$288K-3.7%
Jun 18, 2026Bozic Carmen▼ Sale1,020$462.17$471K-6%
Jun 15, 2026Bozic Carmen▼ Sale4,062$450$1.8M-19.3%
Jun 5, 2026Bozic Carmen▼ Sale1,745$450$785K-7.7%
Jun 1, 2026Liu Joy▼ Sale828$439.91$364K-4%
May 29, 2026Bozic Carmen▼ Sale1,974$450$888K-8%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $VRTX feed.

VRTX Insider Trading — Form 4 Buys & Sells | alphai